These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 26807509

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Liraglutide improved the reproductive function of obese mice by upregulating the testicular AC3/cAMP/PKA pathway.
    Qi R, Liang Y, Yu J, Chen B, Jiang J, Wu X, Lu W, Li Z.
    Reprod Biol Endocrinol; 2024 Mar 20; 22(1):31. PubMed ID: 38509558
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacological efficacy of FGF21 analogue, liraglutide and insulin glargine in treatment of type 2 diabetes.
    Ye X, Qi J, Yu D, Wu Y, Zhu S, Li S, Wu Q, Ren G, Li D.
    J Diabetes Complications; 2017 Apr 20; 31(4):726-734. PubMed ID: 28143735
    [Abstract] [Full Text] [Related]

  • 6. Four weeks administration of Liraglutide improves memory and learning as well as glycaemic control in mice with high fat dietary-induced obesity and insulin resistance.
    Porter DW, Kerr BD, Flatt PR, Holscher C, Gault VA.
    Diabetes Obes Metab; 2010 Oct 20; 12(10):891-9. PubMed ID: 20920042
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Liraglutide improves lipid metabolism by enhancing cholesterol efflux associated with ABCA1 and ERK1/2 pathway.
    Wu YR, Shi XY, Ma CY, Zhang Y, Xu RX, Li JJ.
    Cardiovasc Diabetol; 2019 Nov 09; 18(1):146. PubMed ID: 31706303
    [Abstract] [Full Text] [Related]

  • 9. Effects of liraglutide on lipolysis and the AC3/PKA/HSL pathway.
    Li Z, Yang P, Liang Y, Xia N, Li Y, Su H, Pan H.
    Diabetes Metab Syndr Obes; 2019 Nov 09; 12():1697-1703. PubMed ID: 31564937
    [Abstract] [Full Text] [Related]

  • 10. The Characteristics of Hepatic Gsα-cAMP Axis in HSHF Diet-Fed Obese Insulin Resistance Rats and Genetic Diabetic Mice.
    Xue N, Wei C, Zhang L, Liu H, Wang X, Wang L.
    Biol Pharm Bull; 2017 Jun 01; 40(6):774-781. PubMed ID: 28260721
    [Abstract] [Full Text] [Related]

  • 11. Liraglutide improves hepatic insulin resistance via the canonical Wnt signaling pathway.
    Qin Y, Chen M, Yang Y, Zhou XR, Shao SY, Wang DW, Yuan G.
    Mol Med Rep; 2018 May 01; 17(5):7372-7380. PubMed ID: 29568881
    [Abstract] [Full Text] [Related]

  • 12. Comparative Study of Liraglutide and Insulin Glargine on Glycemic Control and Pancreatic β-Cell Function in db/db Mice.
    Li Y, Zheng J, Shen Y, Li W, Liu M, Wang J, Zhu S, Wu M.
    Med Sci Monit; 2018 May 19; 24():3293-3300. PubMed ID: 29777582
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Reduced expression of ERp46 under diabetic conditions in β-cells and the effect of liraglutide.
    Lampropoulou E, Lymperopoulou A, Charonis A.
    Metabolism; 2016 Jan 19; 65(1):7-15. PubMed ID: 26683792
    [Abstract] [Full Text] [Related]

  • 15. Serum Quantitative Proteomic Analysis Reveals Soluble EGFR To Be a Marker of Insulin Resistance in Male Mice and Humans.
    Kyohara M, Shirakawa J, Okuyama T, Kimura A, Togashi Y, Tajima K, Hirano H, Terauchi Y.
    Endocrinology; 2017 Dec 01; 158(12):4152-4164. PubMed ID: 29028997
    [Abstract] [Full Text] [Related]

  • 16. Liraglutide induces beige fat development and promotes mitochondrial function in diet induced obesity mice partially through AMPK-SIRT-1-PGC1-α cell signaling pathway.
    Zhou J, Poudel A, Chandramani-Shivalingappa P, Xu B, Welchko R, Li L.
    Endocrine; 2019 May 01; 64(2):271-283. PubMed ID: 30535743
    [Abstract] [Full Text] [Related]

  • 17. Liraglutide downregulates hepatic LDL receptor and PCSK9 expression in HepG2 cells and db/db mice through a HNF-1a dependent mechanism.
    Yang SH, Xu RX, Cui CJ, Wang Y, Du Y, Chen ZG, Yao YH, Ma CY, Zhu CG, Guo YL, Wu NQ, Sun J, Chen BX, Li JJ.
    Cardiovasc Diabetol; 2018 Apr 04; 17(1):48. PubMed ID: 29618348
    [Abstract] [Full Text] [Related]

  • 18. Anti-hyperglycemic and hypolipidemic effects of Cistanche tubulosa in type 2 diabetic db/db mice.
    Xiong WT, Gu L, Wang C, Sun HX, Liu X.
    J Ethnopharmacol; 2013 Dec 12; 150(3):935-45. PubMed ID: 24095831
    [Abstract] [Full Text] [Related]

  • 19. Early intervention with glucagon-like peptide 1 analog liraglutide prevents tau hyperphosphorylation in diabetic db/db mice.
    Ma DL, Chen FQ, Xu WJ, Yue WZ, Yuan G, Yang Y.
    J Neurochem; 2015 Oct 12; 135(2):301-8. PubMed ID: 26183127
    [Abstract] [Full Text] [Related]

  • 20. Direct Effect of the Synthetic Analogue of Glucagon-Like Peptide Type 1, Liraglutide, on Mature Adipocytes Is Realized through Adenylate-Cyclase-Dependent Enhancing of Insulin Sensitivity.
    Mamontova ED, Michurina SS, Stafeev IS, Sorkina EL, Sklyanik IA, Koksharova EO, Menshikov MY, Shestakova MV, Parfyonova YV.
    Biochemistry (Mosc); 2021 Mar 12; 86(3):350-360. PubMed ID: 33838634
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.